IRIS
COSTA, CLAUDIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 972
EU - Europa 333
AS - Asia 130
AF - Africa 13
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.449
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 953
IT - Italia 172
CN - Cina 115
NL - Olanda 92
CA - Canada 19
SE - Svezia 15
CI - Costa d'Avorio 13
GB - Regno Unito 12
IE - Irlanda 12
DE - Germania 10
VN - Vietnam 8
FI - Finlandia 7
FR - Francia 4
RO - Romania 3
BD - Bangladesh 2
PL - Polonia 2
UA - Ucraina 2
AE - Emirati Arabi Uniti 1
CY - Cipro 1
DK - Danimarca 1
EU - Europa 1
KR - Corea 1
LU - Lussemburgo 1
PH - Filippine 1
SG - Singapore 1
Totale 1.449
Salva come PNG Salva come JPEG
Città #
Chandler 272
Ashburn 93
Amsterdam 91
Napoli 70
Millbury 53
Boston 46
Des Moines 43
Beijing 41
Lawrence 39
Nanjing 26
Princeton 20
Ottawa 19
Naples 16
Washington 15
Wilmington 15
Los Angeles 11
Hebei 9
Nanchang 9
Dong Ket 8
Fairfield 8
Shenyang 6
Grammichele 5
Jiaxing 5
Tianjin 5
Houston 4
Redwood City 4
Rome 4
Changsha 3
Salerno 3
Woodbridge 3
Wuhan 3
Ann Arbor 2
Asti 2
Chengdu 2
Edinburgh 2
Frankfurt am Main 2
Guangzhou 2
Hangzhou 2
Huddinge 2
Kronberg 2
Latina 2
Magenta 2
Santa Clara 2
Shariakandi 2
Altavilla Irpina 1
Battipaglia 1
Buffalo 1
Capaccio 1
Casavatore 1
Caserta 1
Copenhagen 1
Cosenza 1
Dubai 1
Freiburg im Breisgau 1
Hanover 1
Indiana 1
Kisa 1
Las Vegas 1
Luxembourg 1
Macerata Campania 1
Matera 1
Mountain View 1
Muro Lucano 1
New York 1
Newark 1
Norwalk 1
Pomigliano D'arco 1
Portici 1
Redmond 1
San Mateo 1
San Prisco 1
Serrara Fontana 1
Shenzhen 1
Stockholm 1
Suffern 1
Sunnyvale 1
Vidin 1
Warsaw 1
Totale 1.009
Salva come PNG Salva come JPEG
Nome #
A case of the co-existence of subcorneal pustular dermatosis and pyoderma gangrenosum and a review of the literature 46
BRIT‐1 expression and its relationship with PARP‐1 and CAF‐1/p60 in cutaneous melanoma 46
Dermoscopy of uncommon variants of dermatofibrosarcoma protuberans 45
Complete remission of an advanced basal cell carcinoma after only 3-month treatment with sonidegib: Report of a case and drug management during COVID-19 pandemic 43
Molluscum contagiosum arising next to a scar of the nipple of an excised mammarian fibroadenoma and brief review of literature 42
Advanced basal cell carcinoma treated with vismodegib: impact on the lives of patients and their families 41
How reflectance confocal microscopy can help diagnose an enigmatic variant of dermatofibroma 40
Ingenol Mebutate: When the Patient Refuses Surgery 38
Clinical and dermoscopic features of Spitz nevus by sex, age and anatomical site: a study of 913 Spitz naevi 37
Squamous Cell Carcinomas in Two Cases of Nail Lichen Planus: Is There a Real Association? 36
Melanoma frequency among symmetrical Spitzoid-looking lesions: a retrospective study 35
Reply to Woltsche N. et al. Managing adverse effects by dose reduction during routine treatment of locally advanced basal cell carcinoma with the hedgehog inhibitor vismodegib: a single center experience 35
Management of clinical and subclinical actinic keratoses with histological and immunohistochemical assessments by confocal microscopy 33
Vismodegib treatment in a HIV positive patient on antiretroviral therapy 33
Tissue Expression of Carbonic Anhydrase IX Correlates to More Aggressive Phenotype of Basal Cell Carcinoma 33
Double extramammary Paget's disease 32
Leiomyoma of the finger in a patient affected by cutaneous Kaposi's sarcoma 32
Difficult to diagnose small cutaneous melanoma metastases mimicking angiomas: utility of dermoscopy 32
Merkel Cell Carcinoma: Therapeutic Update and Emerging Therapies 31
A solitary reddish nodule on the upper back of a middle-aged woman 30
Cutaneous Bowen’s disease: An analysis of 182 cases according to age, sex, and anatomical site from an Italian center 30
Clinical, dermoscopic and histological features of a Merkel cell carcinoma of the hand. 29
Appearances may be deceiving 29
Effective and tolerable treatment of advanced basal cell carcinoma with vismodegib despite other malignancies 29
Ein solitärer rötlicher Knoten am oberen Rücken einer Frau mittleren Alters. 28
A case of Paediatric Acrodermatitis Continua of Hallopeau successfully treated with adalimumab biosimilar 28
Deceitful clustered papules on the scalp of a middle-aged woman 28
Dermoscopic patterns of intradermal naevi 28
An atypical pigmented lesion. 27
Nevoid hyperkeratosis of the nipple mimicking a pigmented basal cell carcinoma 26
A case of juvenile amyopathic dermatomyositis 26
Reply to Wong C et al. "Comparison of daily dosing vs. Monday through Friday dosing of vismodegib for locally advanced basal cell carcinoma (laBCC) and basal cell nevus syndrome: a retrospective case series" 26
Intralesional Methotrexate for the Treatment of Keratoacanthoma: The Neapolitan Experience 26
Assessment of the adverse events related to hedgehog pathway inhibitor therapy for basal cell carcinoma: A single-centre retrospective study 26
An atypical pigmented lesion-Answer. 25
The effectiveness of vismodegib in patients with advanced periocular basal cell carcinoma: a case series of 13 patients 25
A rare evolution of porokeratosis 25
Neutrophilic dermatosis in pregnancy: An uncommon course 24
Low-Dose Vismodegib as Maintenance Therapy After Locally Advanced Basal Cell Carcinoma Complete Remission: High Efficacy with Minimal Toxicity 24
Awareness on sun protection behavior among melanoma and nonmelanoma skin cancer patients: An Italian tertiary cancer center experience 24
Hailey-Hailey disease successfully treated with vitamin D oral supplementation 23
Lichenoid rash: A new side effect of oral Cladribine 23
Chronic inducible urticarias in children 22
The remarkable increase of squamous cell carcinomas: a retrospective single-center study of 14-years study period 22
Efficacy and safety of vismodegib in patients with basal cell carcinoma: An Italian Center experience 22
Cutaneous melanoma associated with naevi prevalence: A 15-year cross-sectional retrospective study 20
Real-Life Effectiveness of Vismodegib in Patients with Metastatic and Advanced Basal Cell Carcinoma: Characterization of Adverse Events and Assessment of Health-Related Quality of Life using the Dermatology Life Quality Index (DLQI) Test 18
Waste exposure and skin diseases 16
Comment on: “Second primary melanomas in a cohort of 977 melanoma patients within the first 5 years of monitoring” 16
SkIndia Quiz 32: A strange sessile formation appearing as a penis-like structure 15
Dose reduction during routine treatment of locally advanced basal cell carcinoma with the hedgehog inhibitor sonidegib to manage adverse effects: A retrospective case series 14
Second primary melanoma: incidence rate and risk factors 13
Sonidegib: Safety and Efficacy in Treatment of Advanced Basal Cell Carcinoma 12
Trends in epidemiology of melanoma in situ in a center of South-Italy: Data from a melanoma reference center during the period 2004–2018 11
Patients with advanced basal cell carcinomas in treatment with sonic hedgehog inhibitors during the coronavirus disease 2019 (COVID-19) period: Management and adherence to treatment 8
Hair Loss in Patients Treated with Vismodegib: A Single-Center Retrospective Study 7
Melanoma Screening Days During the Coronavirus Disease 2019 (COVID-19) Pandemic: Strategies to Adopt 7
Response to "Efficacy of sonidegib in histologic subtypes of advanced basal cell carcinoma: Results from the final analysis of the randomized phase 2 Basal Cell Carcinoma Outcomes with LDE225 Treatment (BOLT) trial at 42 months" 7
Development of a Patient-Reported Outcome Measure (PROM) for Dysgeusia During Treatment With Smoothened (SMO) Inhibitors for Basal Cell Carcinomas: The SMO-iD Questionnaire 6
Drug holiday regimen for vismodegib treatment in patients with multiple primary basal cell carcinomas 5
Totale 1.560
Salva come PNG Salva come JPEG
Categoria #
all - tutte 6.624
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.624
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20193 0 0 0 0 0 0 0 0 0 3 0 0
2019/2020150 59 2 1 11 2 0 4 0 1 24 40 6
2020/2021167 10 2 6 21 12 8 6 63 3 24 4 8
2021/2022335 0 0 11 1 2 12 3 8 20 31 95 152
2022/2023576 70 72 18 23 84 50 0 54 81 86 28 10
2023/2024238 12 53 27 24 23 58 1 29 1 10 0 0
Totale 1.560